Expression of cytochrome P450 in lung tumor

被引:21
作者
Gharavi, N [1 ]
El-Kadi, AOS [1 ]
机构
[1] Univ Alberta, Fac Pharm & Pharmaceut Sci, Dent Pharm Ctr 3118, Edmonton, AB T6G 2N8, Canada
关键词
anticancer drugs; cytochrome P450; drug metabolizing enzymes; cancer; lung; tumor;
D O I
10.2174/1389200043489045
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Cytochrome P450 (CYP450) enzymes have the capability of playing key metabolic roles in several aspects of cancer as a consequence of their unusually broad Substrate specificities. CYP450 are also prominent players in the metabolism of anticancer therapeutic drugs, enhancing or diminishing the efficacy of the drugs depending oil whether the drug Or its metabolites are efficacious. As CYP450 enzymes are also found ill lung tissue, lung metabolism can be of importance to the bioactivation of some anticancer agents. The presence of individual forms of CYP450 has been investigated in lung tumor to determine whether intra-tumor metabolism of anticancer agents by CYP450 Could Occur and thus influence the response of tumor to these agents. Differences in drug metabolism between normal and cancerous lung tissue have been shown to exist. therefore: the variable expression of CYP450 between tumor and normal tissue call provide a basis for selective sensitivity of tissue to anticancer drugs. thereby localizing drug actions to tumor. This review gives a detailed picture Of the expression of CYP450 ill lung tumor and the role of this enzyme ill lung tumor in the fate of anticancer drugs.
引用
收藏
页码:203 / 210
页数:8
相关论文
共 102 条
[1]   IMMUNOHISTOCHEMICAL DETECTION OF PULMONARY CYTOCHROME P450IA AND METABOLIC-ACTIVITIES ASSOCIATED WITH P450IA1 AND P450IA2 ISOZYMES IN LUNG-CANCER PATIENTS [J].
ANTTILA, S ;
VAINIO, H ;
HIETANEN, E ;
CAMUS, AM ;
MALAVEILLE, C ;
BRUN, G ;
HUSGAFVELPURSIAINEN, K ;
HEIKKILA, L ;
KARJALAINEN, A ;
BARTSCH, H .
ENVIRONMENTAL HEALTH PERSPECTIVES, 1992, 98 :179-182
[2]   Expression and localization of CYP3A4 and CYP3A5 in human lung [J].
Anttila, S ;
Hukkanen, J ;
Hakkola, J ;
Stjernvall, T ;
Beaune, P ;
Edwards, RJ ;
Boobis, AR ;
Pelkonen, O ;
Raunio, H .
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 1997, 16 (03) :242-249
[3]   SMOKING AND PERIPHERAL TYPE OF CANCER ARE RELATED TO HIGH-LEVELS OF PULMONARY CYTOCHROME-P450IA IN LUNG-CANCER PATIENTS [J].
ANTTILA, S ;
HIETANEN, E ;
VAINIO, H ;
CAMUS, AM ;
GELBOIN, HV ;
PARK, SS ;
HEIKKILA, L ;
KARJALAINEN, A ;
BARTSCH, H .
INTERNATIONAL JOURNAL OF CANCER, 1991, 47 (05) :681-685
[4]   EXPRESSION OF PULMONARY CYTOCHROME P4501A1 AND CARCINOGEN DNA ADDUCT FORMATION IN HIGH-RISK SUBJECTS FOR TOBACCO-RELATED LUNG-CANCER [J].
BARTSCH, H ;
CASTEGNARO, M ;
ROJAS, M ;
CAMUS, AM ;
ALEXANDROV, K ;
LANG, M .
TOXICOLOGY LETTERS, 1992, 64-5 :477-483
[5]  
BLOKHINA NG, 1972, CANCER-AM CANCER SOC, V30, P390, DOI 10.1002/1097-0142(197208)30:2<390::AID-CNCR2820300214>3.0.CO
[6]  
2-E
[7]   Variability of cyclophosphamide uptake into human bronchial carcinoma: consequences for local bioactivation [J].
Bohnenstengel, F ;
Friedel, G ;
Ritter, CA ;
McClellan, M ;
Fritz, P ;
Eichelbaum, M ;
Linder, A ;
Toomes, H ;
Dierkesmann, R ;
Kroemer, HK .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2000, 45 (01) :63-68
[8]   TISSUE-SPECIFIC EXPRESSION AND METHYLATION OF THE HUMAN CYP2E1 GENE [J].
BOTTO, F ;
SEREE, E ;
ELKHYARI, S ;
DESOUSA, G ;
MASSACRIER, A ;
PLACIDI, M ;
CAU, P ;
PELLET, W ;
RAHMANI, R ;
BARRA, Y .
BIOCHEMICAL PHARMACOLOGY, 1994, 48 (06) :1095-1103
[9]   HYPOMETHYLATION AND HYPOEXPRESSION OF HUMAN CYP2E1 GENE IN LUNG-TUMORS [J].
BOTTO, F ;
SEREE, E ;
ELKHYARI, S ;
CAU, P ;
HENRIC, A ;
DEMEO, M ;
BERGERON, P ;
BARRA, Y .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1994, 205 (02) :1086-1092
[10]   The discovery of the potent and selective antitumour agent 2-(4-amino-3-methylphenyl)benzothiazole (DF 203) and related compounds [J].
Bradshaw, TD ;
Stevens, MFG ;
Westwell, AD .
CURRENT MEDICINAL CHEMISTRY, 2001, 8 (02) :203-210